Vaccinia virus is a large enveloped poxvirus with more than 200 genes in its genome. Although many poxvirus genomes have been sequenced, knowledge of the host and viral protein components of the virions remains incomplete. In this study, we used gel-free liquid chromatography and tandem mass spectroscopy to identify the viral and host proteins in purified vaccinia intracellular mature virions (IMV). Analysis of the proteins in the IMV showed that it contains 75 viral proteins, including structural proteins, enzymes, transcription factors, and predicted viral proteins not known to be expressed or present in the IMV. We also determined the relative abundances of the individual protein components in the IMV. Finally, 23 IMV-associated host proteins were also identified. This study provides the first comprehensive structural analysis of the infectious vaccinia virus IMV.
Vaccinia virus is the prototype virus of the orthopoxvirus genus in the family Poxviridae, which replicates in the cytoplasm of cells (57, 104) and encodes more than 200 open reading frames (ORFs) in a 190-kb double-stranded DNA genome. Vaccinia virus infection produces multiple forms of infectious particles, namely, intracellular mature virions (IMV), intracellular enveloped virions (IEV), cell-associated enveloped virions (CEV), and extracellular enveloped virions (EEV). The IMV is the most abundant virion, with a single membrane in cells; however, the origin of the membrane is unknown (75, 77) . A portion of the IMV is subsequently wrapped with two layers of Golgi membrane to form an IEV, which is transported through microtubules to the cell periphery and loses one membrane during virion egress to become a CEV (130, 140, 152, 153) . The CEV remains associated with the cell surface, where actin-containing microvilli are formed, or can be released by host cell Src/Abl kinases into the medium to become an EEV (41, 42, 61, 111, 156) . The IMV is robust and is known to be resistant to environmental and physical changes, whereas the CEV and EEV are very fragile, and the integrity of their outer membranes can be destroyed during purification procedures (83) .
Many of the poxvirus genomes, including those of different strains of vaccinia virus, have been sequenced (http://www .poxvirus.org/viruses.asp). The genome of the vaccinia virus Western Reserve (WR) strain contains 218 potential ORFs; however, the existence of an ORF does not necessarily reveal the existence of a protein or the location of the protein. While classical biochemical and genetic approaches have generated significant knowledge of viral-gene functions, the physical composition of vaccinia virus IMV particles remains unknown.
Previous researchers have analyzed the protein composition of the vaccinia virus IMV. Initial studies of the purified IMV led to the identification on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of 17 "regions" containing 31 to 48 protein bands (103, 115, 139) . Essani and Dales increased the gel resolution and detected 56 polypeptide bands on SDS-PAGE (54) . Using different gel electrophoretic conditions, Oie and Ichihashi found 84 protein spots that could be assigned to 52 protein species in purified IMV (116) . Unfortunately, the naming system for vaccinia virus proteins in the above studies was based on the protein migration behavior on gels, making it difficult to compare data generated in different gel electrophoresis systems. In addition, the majority of viral genes encode proteins smaller than 50 kDa that tend to cluster together and are difficult to resolve by SDS-PAGE. Moreover, N-terminal sequencing of viral protein bands on gels revealed that multiple protein bands can be derived from a single viral gene as a result of posttranslational cleavage or modification and that the 40 to 50 IMV bands seen on gels were derived from only 12 viral genes (160) . Similarly, Jensen et al. found that the purified vaccinia virus core and membrane contain 30 proteins encoded by 13 viral genes and 5 host genes; additional, less abundant virion components were detected but not identified (86) .
Mass spectrometry (MS), in particular, tandem MS (MS/ MS), provides a powerful tool for proteome analysis because it is much more sensitive than other methods, can deal with protein mixtures, and offers a high throughput (120) . Washburn et al. identified 1,484 proteins in the yeast proteome using gel-free liquid chromatography and tandem mass spectroscopy (LC/MS/MS) (175) . Similar analyses have been used to identify virion proteins in human and murine cytomegalovirus, Epstein-Barr virus, and Kaposi's sarcoma-associated herpesvirus (87, 92, 172, 191) . The identification of virion proteins makes it possible to start determining how the proteins interact, their stoichiometry in the viral particle, and which cellular compartments are involved in virion formation. In this study, we used LC/MS/MS analysis to determine the viral and host proteins that comprise each IMV particle. New components of vaccinia virus IMV encoded by putative ORFs were discovered, and the relative abundance of each component in the IMV was determined.
MATERIALS AND METHODS
Cells, virus, and reagents. HeLa cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Vaccinia virus (Western Reserve strain) was propagated in HeLa cells and purified as described previously (80, 86) . In brief, the infected cells were harvested when the cytotoxic pathological effect was complete. All stages of purification were performed at 4°C. The cells were centrifuged at 850 ϫ g for 15 min to remove the medium and washed three times with phosphate-buffered saline. The pelleted cells were resuspended in TM buffer (10 mM Tris, pH 7.4, 5 mM MgCl 2 ), and the suspension was passed 20 times in a Dounce homogenizer to break the cells. Nuclei were removed by centrifugation at 850 ϫ g for 10 min, and the supernatant, containing virions, was laid on top of 36% sucrose solution and centrifuged at 45,000 ϫ g for 80 min in a Beckman SW28 rotor. The virus pellet was resuspended in TM buffer, sonicated, and further purified by centrifugation through a continuous 25 to 40% sucrose gradient at 27,500 ϫ g for 40 min in a Beckman SW28 rotor. Fractions were taken, and the virion infectivity in each fraction was analyzed by a plaque formation assay. Fractions containing virions were diluted fourfold in TM buffer and centrifuged to pellet the IMV. The purity of the IMV was confirmed by electron microscopy of negatively stained preparations. No detectable cellular debris was found in these preparations.
Tryptic and lysine C digestion of IMV particles. Purified IMV (9 to 50 g) were incubated at 25°C overnight with 0.5 N cyanogen bromide (Fluka) in 90% formic acid (Fluka) to cleave the proteins into smaller polypeptides, and excess reagents were removed by vacuum drying. The polypeptides were denatured and reduced at 37°C for 1 h in 6 M urea (Sigma), 2 M thiourea (Riedel-de Haën), and 10 mM dithiothreitol (Pharmacia Biotech), and then iodoacetamide (Sigma) was added to a final concentration of 20 mM and the sample was incubated at 37°C for 1 h in the dark. The peptide mixture was then diluted eightfold with 100 mM ammonium bicarbonate (Sigma), and sequencing-grade porcine trypsin (Promega) or Lys-C (Wako) was added at a substrate-to-enzyme ratio of 20:1 (wt/wt), and the mixture was incubated at 37°C overnight. The peptides formed were desalted using a C 18 trap, lyophilized on a SpeedVac, and stored at Ϫ80°C. Two-dimensional chromatography. The peptide mixture from 50 g of IMV was fractionated by two-dimensional chromatography (strong cation-exchange chromatography [SCX]-reverse-phase liquid chromatography). The first dimension, SCX, was eluted with a linear gradient of 0 to 300 mM KCl in 5 mM ammonium formate, pH 3.0. The peptides eluted from the SCX column were trapped in two C 18 reverse-phase traps operating alternately; the bound peptides were eluted at 2-min intervals and collected on a fraction collector; a total of 22 fractions were collected. The amount of peptide in each fraction was estimated from the UV absorption at 214 nm.
Mass spectrometry. Mass spectrometric analysis was performed on a nanoscale LC-tandem mass spectrometry (quadrupole time-of-flight mass spectrometer; QStar XL; Applied Biosystems). The instrument setup was as follows. The data files completed from the LC-MS runs were converted to Mascot generic-format files using the Mascot.dll script supplied with the Analyst QS software. The Mascot software package (Matrix Science) was used for database searching and protein identification using the modified vaccinia virus protein database. Peptide mass tolerance and fragment mass tolerance were set at 100 ppm and 0.25 Da, respectively, for the initial search. An alternative calibration algorithm based on Mascot protein identifications was applied to the raw data file to give mass accuracies within 20 ppm.
Proteomic analysis of IMV-derived peptides and database generation. Individual MS/MS spectra were submitted to analysis using MASCOT version 2.0 (Matrix Science Inc.) and searched against the Human International Protein Index protein sequence database (version 3.10; 57,478 protein sequences; European Bioinformatics Institute [http://www.ebi.ac.uk/IPI/]) or against a modified vaccinia virus protein database. The modified viral-protein database combines 218 protein sequences of the WR strain of vaccinia virus obtained from http: //poxvirus.org, 64 nonredundant Copenhagen strain orthologs, and 12 additional peptide sequences predicted from WR viral genome sequences using two programs, GeneMarkS (http://opal.biology.gatech.edu/GeneMark/) and fgenesV (http://softberry.com; 17). These databases allowed the identification of novel vaccinia virus proteins by an exhaustive search of all possible virus-derived peptide sequences. Proteins were scored using a probability-based MOWSE algorithm, and the scores were reported in the form Ϫ10 ϫ log(P), where P is the probability that the observed match is a random event (123) . Matches with scores higher than the 95% confidence level were regarded as significant. In all searches, phosphorylation, methionine oxidation, homoserine lactone, and carbamidomethylation of cysteine residues were considered as possible modifications. In order to increase the data confidence, the same data sets were submitted for a search against a "reverse database," in which all peptide sequences were put in reverse order in silico; the percentage of peptides identified in the reverse database was less than 3.5%, confirming the specificity of the data search. Individual peptide interpretations were classed as significant if the MASCOT MOWSE score for the MS/MS spectra was greater than the cutoff value of 25.
Relative quantification of MS. Quantification of protein abundance in IMV was performed based on the criteria and equations defined previously (85) . In brief, the relative abundances of the proteins were estimated using an exponentially modified protein abundance index (emPAI) approach, which is based on the correlation of peptides identified in MS/MS experiments with observable
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RESULTS
Identification of IMV proteins. Vaccinia IMV particles were purified from the lysates of HeLa cells infected with the vaccinia virus WR strain, using two consecutive sucrose purification procedures to achieve maximal purity. The purified IMV particles were examined by electron microscopy to ensure that the virions had normal virion morphology and that cellular organelles and debris were undetectable. Proteins in purified virions were separated on 12% SDS-PAGE and silver stained (Fig. 1A) . Gel electrophoresis of the purified virions followed by in-gel digestion often causes loss of proteolytic fragments generated from low-abundance proteins, and the gel matrix is inherently not optimal for resolving proteins of low molecular weight. Thus, a gel-free scheme with two-stage proteolysis was adopted to facilitate the efficient extraction of peptides from purified IMV particles. The purified IMV were completely dissolved in 90% formic acid and subjected to cyanogen bromide cleavage, followed by tryptic digestion in solution to sequentially yield a mixture of peptides. Alternatively, proteolytic digestion with Lys-C was performed in order to preserve longer peptides for better quality in data acquisition. These peptides were then analyzed by MS/MS using a modified vaccinia virus (WR) protein database constructed (see Materials and Methods) to include all predicted vaccinia virus translation products, as the commonly used vaccinia virus (WR) strain a The data presented in Table 1 are compiled from three different IMV preparations. Tryptic digestions of different IMV preparations revealed 92% reproducibility, and Lys-C digestions revealed 87% reproducibility. Peptides generated by both trypsin and Lys-C are required to obtain a total of 75 viral proteins: 65 proteins (86.7%) were detected in peptides generated by either trypsin or Lys-C digestions, 9 proteins (12%) were detected only in trypsin-digested peptides, and 1 protein (1.3%) was detected only in Lys-C-digested peptides. VACV, vaccinia virus; CP, Copenhagen strain; ssDNA, single-stranded DNA; ssRNA, single-stranded RNA.
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on September 8, 2017 by guest http://jvi.asm.org/ protein database does not include all predicted viral proteins or small proteins with fewer than 50 amino acids. As shown in Fig. 1B , the MS/MS spectrum of a tryptic peptide was interpreted as HAFDAPTLYVK, one of 30 unique peptides identified in a putative protein, WR062/E6R, resulting in 53% sequence coverage (Fig. 1C) . Another tryptic peptide, ADED DNEETLK, was identified in an envelope protein, A27L (Fig.  1D) , that contains 71% sequence coverage, as shown in Fig.  1E . A total of three different IMV preparations were used in five independent mass spectrometry analyses. Combining the peptide data generated from trypsin and Lys-C digests, we identified 75 viral proteins in the IMV (Table 1) . Because the gene names in the vaccinia virus WR strain are not as widely used as their orthologs in the Copenhagen strain, the latter gene names are used to refer to the viral translation products we identified in this work. Of these, 69 were identified by at least two trypsin-or Lys-C-generated peptides, while the other 6 (C6L, I5L, A9L, A21L, A22R, and A31R) were identified by single peptide hits in the trypsin-or Lys-C-digested samples. A further study using two-dimensional chromatographic fractionation to separate peptides prior to MS/MS was performed (SCX-LC/MS/MS), and at least one extra peptide (each) was identified for C6L, A9L, A21L, and A31R (Table 2 ). All the extra peptides identified in the SCX-LC/MS/MS study had MASCOT scores of at least Ͼ28. No extra peptide was identified for I5L and A22R by SCX-LC/MS/MS, although the same peptides as in one-dimensional LC/MS/MS were reproducibly detected. Both proteins are included in Table 1 , because they were previously detected in the IMV (63, 84, 160) . Of the 75 viral proteins identified, 65 were consistent with previous reports of their presence in IMV particles (references in Table 1 ); these were 22 membrane proteins (H3L, D8L, H2L, L1R, L5R, A2.5, A9L, A13L, A14L, A17L, A21L, A25L, A26L, A27L, A28L, E8R, E10R, F9L, I2L, I5L, J1R, and D13L), 12 core proteins (A3L, A4L, A10L, A30L, F17R, E11L, I1L, I3L, G7L, L4R, D2L, and D3R), 24 enzymes [kinase (F10L), phosphatase (H1L), glutaredoxins (G4L and O2L), topoisomerase (H6R), proteinases (G1L and I7L), ATPase (D11L), poly(A) polymerase subunits (E1L and J3R), capping enzymes (D1R and D12L), DNA-dependent RNA polymerase complexes (A5R, A24R, A29L, J4R, J6R, H4L, E4L, G5.5R, and D7R), helicases (I8R and A18R), and endonuclease (A22R)], 3 viral transcription factors (A7L, H5R, and D6R), and 4 proteins (A42R, A45R, A46R, and F8L) interacting with host proteins. This shows that our proteomic data are reliable and consistent with previous results. More importantly, the proteomic data revealed 10 new viral proteins present in IMV, consisting of the products of seven former putative ORFs (E6R, G3L, L3L, A6L, A15L, A31R, and C6L) and three proteins (K4L, G9R, and A16L) previously with unknown locations and functions. K4L shows homology with phospholipase D but is nonessential for viral growth in cell cultures (21, 24, 122) , while both G9R and A16L have been identified as myristylated proteins in virus-infected cells (102) .
Six viral proteins, I6L, G5R, A12L, A14.5, A32L, and B1R, have been cited in the literature as being IMV associated but were not identified in our analyses (Table 3) (19, 34, 43, 48, 68, 99, 160) . All six proteins were not detected in LC/MS/MS using different IMV preparations, although three proteins (A12L, A32L, and B1R) were detected in SCX-LC/MS/MS, suggesting that the abundances of these three proteins were below the threshold of LC/MS/MS and that SCX chromatography was necessary to reduce the sample complexity in order to enhance the detection sensitivity (Table 3) . Consistent with our interpretation, A32L was previously shown to be difficult to detect in purified IMV (34) . The other three proteins (I6L, G5R, and A14.5L) were not identified in either LC/MS/MS or SCX-LC/ MS/MS analyses. Several possible reasons may explain why they were not detected in both MS/MS analyses. First, MS is biased against small and hydrophobic proteins. A14.5L contains 53 amino acids, producing at most two tryptic peptides (19) . It is also very hydrophobic, with a grand average of hydropathicity index of 1.438 (96) . These features of A14.5L may have jeopardized its detection in MS analyses. Second, MS, despite great sensitivity, can only detect peptides at femtomole range. Third, peptides that are too close to be resolved in MS will also be ignored by data acquisition software. We speculate that these technical reasons might explain the lack of detection of G5R and I6L.
Relative abundances of viral proteins in the IMV. The quantity of each viral component within the IMV particle is an important issue, but it has been difficult to address in the past. Crude estimation of the quantity of each protein by gel staining intensity is not suitable for complex structure analysis. While (85) , which fully utilizes the advantages of the wide dynamic detection range provided by LC/MS analysis and reliable protein search algorithms. This approach to determining the relative abundances of proteins in a complex protein mixture is based on the correlation of peptides identified by tandem MS with observable peptides obtained by in silico digestion. The abundance of each protein determined in this study is presented as the molar and weight percentages of the total protein molecules in IMV particles (Table 4 ). The most abundant viral-protein group (weight percentage, Ͼ5) consisted of four core proteins (A4L, A10L, F17R, and A3L). The relatively abundant protein group (5 Ͼ weight percentage Ͼ 1) consisted of seven envelope proteins (A27L, A25L, A14L, H3L, A26L, D8L, and A13L,), two core proteins (L4R and G7L), four proteins involved in transcription (D11L, J6R, A24R, and D1R), and one novel protein (E6R). Eleven of the above 18 abundant proteins have been previously identified as abundant proteins in IMV particles (86, 160) . The intermediate-abundance protein group (1% Ͼ weight percentage Ͼ 0.5%) contained 15 viral proteins, and the less abundant group (weight percentage, Ͻ0.5%) contained 41 viral proteins. The distribution of viral proteins based on different molar or weight abundances in IMV revealed a similar distribution (Fig. 2) ; the low abundances of many proteins explain why they have escaped previous proteomic detection.
Identification of host proteins associated with the IMV. The host protein content of vaccinia virus IMV was determined by comparing the detected peptides with a Human International Protein Index protein sequence database, and 23 host proteins associated with vaccinia virus IMV particles were identified (Table 5 ). All were present at low abundance (intermediate and less abundant categories) in virions and could be divided into several categories, namely, calcium binding proteins (annexin A1 and A2), chaperon proteins (cyclophilin A, Hsc71, and Hsp90), cytoskeleton proteins (actin, tubulin, and myosin), chromosome architecture proteins (histone and HMG1), translation components (eIF4A-1, eIF1␣-1-1, and 60S ribosomal protein), protein transport/vesicular-trafficking proteins (ADP ribosylation factors1/3 and 4, Rab7, Rab10, and ubiquitin), and proteins involved in redox regulation (thioredoxin and peroxiredoxin 1). Of these host proteins, cyclophilin A, ␤-actin, and ubiquitin have been previously reported as components of vaccinia virus IMV particles (35, 86, 176) , and another 13 have been reported in other viruses (Table 5) (22, 87, 92, 172, 191) . Thus, seven host proteins (60S acidic ribosomal proteins, 66-kDa protein, ADP ribosylation factor 4, HMG1, peroxiredoxin 1, Rab10, and thioredoxin) were found to be associated with vaccinia virus IMV and have not yet been detected in other viruses.
DISCUSSION
Proteomic techniques are widely used to identify protein components of large complexes that participate in different biological processes. MS remains the most suitable tool, as it is fast, sensitive, and widely applicable. Current high-sensitivity methods using MS for protein identification have greatly lowered detection limits, making it easy to analyze proteins with low cell copy numbers. In addition, the quality of bioinformatics continues to improve, making the prediction of gene products deduced from genome information increasingly accurate when MS data are matched to known protein sequences. The use of nano-LC for the high-resolution separation of digested peptides and nano-electrospray ionization/MS analysis allows protein detection in the low femtomole range in routine analysis. This approach can also be used to complement traditional biochemical methods of elucidating viral structures and functions and determining the number and nature of proteins within a virus. In this study, we identified 75 viral and 23 host proteins associated with purified vaccinia virus IMV particles, a significant increase from previous studies (86, 160). Ten novel viral proteins were identified in IMV (Table 1) . EEVspecific viral proteins, such as F13L, A33R, A34R, A36R, and B5R, and viral nonstructural proteins, such as A11R, were not detected in our analyses, supporting the idea that the 10 novel viral proteins are not just copurified lysate contaminants (129, 137) . If we include the additional six virion proteins cited from the literature (Table 3) , there are a total of 81 viral proteins in IMV. Furthermore, the relative abundance of each viral and host protein in IMV was determined by calculating the emPAI value, providing important quantification information for proteomic experiments. The most abundant viral proteins were in general agreement with previous reports (86), validating our quantification methods. In addition, our analysis also revealed that a significant proportion of virion proteins were present at low abundance. It is worth noting that the quantification method based on the emPAI value is fairly new, and the relative abundance would be better utilized to compare proteins of different abundance groups (Fig. 2 ) rather than to compare proteins within the same low-abundance group.
In addition to the viral proteins, 23 IMV-associated host proteins were identified. Compared with the data reproducibility of 75 viral proteins obtained from different IMV preparations, the host proteins indeed revealed somewhat more variation from one preparation to another. Several, such as ARF1/3, ARF 4, Rab-7, and Rab-10, are involved in transport and vesicle trafficking, and their association with IMV particles may be due to the intracellular route taken by the IMV during virion egress. Some host proteins, such as tubulin, actin, annexin A2, cyclophilin A, Hsc71, and Hsp90, have been identified in other virions, such as human cytomegalovirus, murine cytomegalovirus, and adenovirus (Table 3) . It is worth noting that our previous study (82) showed a transient association of Hsp90 with viral factories in cells, while no Hsp90 was detected by immunoblot analysis in purified IMV. Since MS/MS is much more sensitive than immunoblot detection, this discrepancy could be due to the low abundance of Hsp90 associated with viral particles. Although we cannot rule out the possibility that some of the cytoskeleton and chaperon proteins could be fortuitously associated with viral particles during IMV preparation, as previously shown by Franke and Hruby (58) abundant host proteins, such as myosin and vimentin, were not detected in purified IMV. Also, we did not detect host proteins that are known to be on vaccinia virus EEV, i.e., CD46, CD59, CD29, CD71, CD81, and MHC-1 (170) . We also did not detect CD55, moesin, and cofilin, which were frequently identified in other viruses, such as human T-cell leukemia/lymphoma virus type 1, human immunodeficiency virus, and human cytomegalovirus, implying that host protein association with vaccinia virus IMV has some selectivity (92, 119, 136, 154, 172) . Interestingly, six host proteins were uniquely identified in vaccinia virus, and their roles in vaccinia virus biology need to be studied in the future.
